OrphAI Therapeutics
OrphAI Therapeutics develops targeted drug candidates for rare diseases and specific cancers, focusing on conditions such as pulmonary hypertension and bronchiolitis obliterans. The company addresses the unmet medical needs of patients by utilizing advanced drug development techniques to create life-saving therapies.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- OrphAI Therapeutics develops targeted drug candidates for rare diseases and specific cancers, focusing on conditions such as pulmonary hypertension and bronchiolitis obliterans. The company addresses the unmet medical needs of patients by utilizing advanced drug development techniques to create life-saving therapies.